AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Apr 5, 2017
34395_dirs_2017-04-05_415a5d42-27d0-4bf0-841a-f42967713a83.zip
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-04-03
Reporting Person: Faulkes Martin Charles (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-03 | Common Stock | X | 58034 | $2.6 | Acquired | 1351284 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-03 | Warrant (Right to Buy) | $2.6 | X | 58034 | Disposed | 2017-05-10 | Common Stock (58034) | Direct |